Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;7(2):e001568.
doi: 10.1136/rmdopen-2021-001568.

Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden

Affiliations

Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden

Anton Jonatan Landgren et al. RMD Open. 2021 May.

Abstract

Objectives: We aimed to compare traditional (trad) cardiovascular risk factors (CVRFs) among patients with gout, psoriatic arthritis (PsA), rheumatoid arthritis (RA) and ankylosing spondylitis (AS) stratified by sex.

Methods: A survey was sent to patients with gout (n=1589), PsA (n=1200), RA (n=1246) and AS (n=1095). Patients were retrieved from Sahlgrenska University Hospital, the hospitals of Uddevalla and Skövde, and 12 primary care centres in Western Sweden. The prevalence of self-reported trad-CVRFs was compared between diagnoses by age standardisation with the 2018 population of Sweden as the standard population.

Results: In total, 2896 (56.5%) of 5130 patients responded. Hypertension was the most frequently found comorbidity, reported by 65% of patients with gout, 41% with PsA, 43% with RA and 29% with AS. After age standardisation, women and men with gout had significantly more obesity (body mass index ≥30 kg/m2), hypertension, diabetes, hyperlipidaemia and multiple trad-CVRFs, compared with those with PsA, RA and AS. Obesity was significantly more common in PsA than in RA. In women, obesity, hypertension and multiple trad-CVRFs were more frequently reported in PsA than in RA and AS, whereas similar prevalence of CVRFs and coexistence of multiple trad-CVRFs were found in men with PsA, RA and AS.

Conclusions: Women and men with gout had the highest prevalence of trad-CVRFs. Differences in occurrence of CVRFs by sex were found in patients with PsA, RA and AS. In women, patients with PsA had higher occurrence of trad-CVRFs than those with RA and AS, whereas in men the distribution of CVRFs was similar in PsA, RA and AS.

Keywords: ankylosing spondylitis; epidemiology; gout; psoriatic arthritis; rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Patient selection. AS, ankylosing spondylitis; PsA, psoriatic arthritis; RA, rheumatoid arthritis.
Figure 2
Figure 2
(A) Age-standardised prevalence and comparison between different IJDs for different levels of multiple traditional (trad) CVRFs in women (ages 45–89 years, n=960). (B) Age-standardised prevalence and comparison between different IJDs for different levels of multiple trad-CVRFs in men (ages 30–89 years, n=1643). AS, ankylosing spondylitis; CVRF, cardiovascular risk factor; IJD, inflammatory joint disease; PsA, psoriatic arthritis; RA, rheumatoid arthritis. # Body mass index ≥30 kg/m2, hypertension, diabetes, hyperlipidaemia, current smoking, total sitting time ≥7 hours per day+physical activity ≤3 hours per week.

References

    1. Agca R, Heslinga SC, Rollefstad S, et al. . EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017;76:17–28. 10.1136/annrheumdis-2016-209775 - DOI - PubMed
    1. Bengtsson K, Forsblad-d'Elia H, Lie E, et al. . Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther 2017;19:102. 10.1186/s13075-017-1315-z - DOI - PMC - PubMed
    1. Drivelegka P, Sigurdardottir V, Svärd A, et al. . Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Res Ther 2018;20:108. 10.1186/s13075-018-1596-x - DOI - PMC - PubMed
    1. Kuo C-F, Grainge MJ, Mallen C, et al. . Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis 2016;75:210–7. 10.1136/annrheumdis-2014-206410 - DOI - PMC - PubMed
    1. Jamnitski A, Symmons D, Peters MJL, et al. . Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2013;72:211–6. 10.1136/annrheumdis-2011-201194 - DOI - PubMed

Publication types